Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review (vol 11, pg 1, 2019)

被引：0
|
作者：
Chiorean, Elena Gabriela
Cheung, Winson Y.
Giordano, Guido
Kim, George
Al-Batran, Salah-Eddin
机构：
来源：
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 2019年 / 11卷
关键词：
D O I：
10.1177/1758835919871363
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally advanced pancreatic cancer patients
    Ingram, Myles A.
    Lauren, Brianna N.
    Pumpalova, Yoanna
    Park, Jiheum
    Lim, Francesca
    Bates, Susan E.
    Kastrinos, Fay
    Manji, Gulam A.
    Kong, Chung Yin
    Hur, Chin
    CANCER REPORTS, 2022, 5 (09)
  • [22] Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
    Williet, Nicolas
    Petrillo, Angelica
    Roth, Gael
    Ghidini, Michele
    Petrova, Mila
    Forestier, Julien
    Lopez, Anthony
    Thoor, Audrey
    Weislinger, Lucie
    De Vita, Ferdinando
    Taieb, Julien
    Phelip, Jean Marc
    CANCERS, 2021, 13 (11)
  • [23] Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Pusceddu, Sara
    Ghidini, Michele
    Torchio, Martina
    Corti, Francesca
    Tomasello, Gianluca
    Niger, Monica
    Prinzi, Natalie
    Nichetti, Federico
    Coinu, Andrea
    Di Bartolomeo, Maria
    Cabiddu, Mary
    Passalacqua, Rodolfo
    de Braud, Filippo
    Petrelli, Fausto
    CANCERS, 2019, 11 (04)
  • [24] Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china
    Cui, Jiujie
    Zhang, Xiaochen
    Qu, Shuli
    Wang, Liwei
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 691 - 697
  • [25] Comparisons of Outcomes of Real-World Patients With Advanced Pancreatic Cancer Treated With FOLFIRINOX Versus Gemcitabine and Nab-Paclitaxel A Population-Based Cohort Study
    Papneja, Neha
    Zaidi, Adnan
    Chalchal, Haji
    Moser, Michael
    Tan, Kiat
    Olson, Colleen
    Haider, Kamal
    Shaw, John
    Ahmed, Shahid
    PANCREAS, 2019, 48 (07) : 920 - 926
  • [26] Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
    Sunnie Kim
    James E. Signorovitch
    Hongbo Yang
    Oscar Patterson-Lomba
    Cheryl Q. Xiang
    Brian Ung
    Monika Parisi
    John L. Marshall
    Advances in Therapy, 2018, 35 : 1564 - 1577
  • [27] Gemcitabine plus Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
    Zaibet, Simon
    Hautefeuille, Vincent
    Auclin, Edouard
    Lievre, Astrid
    Tougeron, David
    Sarabi, Mathieu
    Gilabert, Marine
    Wasselin, Julie
    Edeline, Julien
    Artru, Pascal
    Bechade, Dominique
    Morin, Clemence
    Ducoulombier, Agnes
    Taieb, Julien
    Pernot, Simon
    BRITISH JOURNAL OF CANCER, 2022, 126 (10) : 1394 - 1400
  • [28] Chemotherapy in Pancreatic Cancer: Comparative Study of Gemcitabine, S-1, and FOLFIRINOX, Nab-Paclitaxel plus Gem
    Miyata, H.
    Yamago, H.
    Ueki, H.
    Nagamatsu, K.
    Iwasaki, R.
    PANCREAS, 2019, 48 (10) : 1492 - 1492
  • [29] Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
    Kim, Sunnie
    Signorovitch, James E.
    Yang, Hongbo
    Patterson-Lomba, Oscar
    Xiang, Cheryl Q.
    Ung, Brian
    Parisi, Monika
    Marshall, John L.
    ADVANCES IN THERAPY, 2018, 35 (10) : 1564 - 1577
  • [30] FOLFIRINOX versus gemcitabine nab-paclitaxel for advanced pancreatic cancer: KU Cancer Center experience.
    Kasi, Anup
    Middinti, Akshay
    Cao, An
    Vekaria, Pratikkumar
    Patel, Devangi
    Subramaniam, Dipti
    Chen, Guoqing J.
    Saeed, Anwaar Mohammed
    Paluri, Ravi Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345